Literature DB >> 35389960

Rapid Resolution of Prolonged Benzodiazepine-Refractory Catatonia With Electroconvulsive Therapy in an Adolescent Patient: A Case Report.

James Luccarelli, Carlos Fernandez-Robles, Bryce Wininger, Jessica E Becker, Eric P Hazen, Michael E Henry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35389960      PMCID： PMC9420753          DOI： 10.1097/YCT.0000000000000841

Source DB:  PubMed          Journal:  J ECT        ISSN： 1095-0680            Impact factor:   3.692


× No keyword cloud information.
  6 in total

1.  Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.

Authors:  G S Ungvari; H F Chiu; L Y Chow; B S Lau; W K Tang
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

2.  Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study.

Authors:  Angèle Consoli; Marie Raffin; Claudine Laurent; Nicolas Bodeau; Dominique Campion; Zahir Amoura; Frederic Sedel; Isabelle An-Gourfinkel; Olivier Bonnot; David Cohen
Journal:  Schizophr Res       Date:  2012-03-07       Impact factor: 4.939

3.  Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia.

Authors:  Marie Raffin; Laetitia Zugaj-Bensaou; Nicolas Bodeau; Vanessa Milhiet; Claudine Laurent; David Cohen; Angèle Consoli
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-27       Impact factor: 4.785

Review 4.  Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response.

Authors:  Federica Luchini; Pierpaolo Medda; Michela Giorgi Mariani; Mauro Mauri; Cristina Toni; Giulio Perugi
Journal:  World J Psychiatry       Date:  2015-06-22

5.  The Response to an Amobarbital Interview as a Predictor of Therapeutic Outcome in Patients with Catatonic Mutism.

Authors:  W. Vaughn McCall
Journal:  Convuls Ther       Date:  1992

6.  Demographics of Patients Receiving Electroconvulsive Therapy Based on State-Mandated Reporting Data.

Authors:  James Luccarelli; Michael E Henry; Thomas H McCoy
Journal:  J ECT       Date:  2020-12       Impact factor: 3.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.